Article
Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
Cancer research - 15 Sept 2005
Buchanan Grant, Birrell Stephen N, Peters Amelia A, Bianco-Miotto Tina, Ramsay Katrina, Cops Elisa J, Yang Miao, Harris Jonathan M, Simila Henry A, Moore Nicole L, Bentel Jacqueline M, Ricciardelli Carmella, Horsfall David J, Butler Lisa M, Tilley Wayne D
Abstract excerpt
Previously, we reported that androgen receptor (AR), but not estrogen receptor (ER) or progesterone receptor (PR), is predictive of response to the synthetic progestin, medroxyprogesterone acetate (MPA), in a cohort of 83 patients with metastatic breast cancer. To further investigate the role of AR in determining response to MPA in this cohort, we analyzed AR levels by immunohistochemistry with two discrete...
Topics
- Animals
- Antineoplastic Agents, Hormonal
- Breast Neoplasms
- COS Cells
- Cell Line, Tumor
- Chlorocebus aethiops
- Drug Resistance, Neoplasm
- Female
- Humans
